WVE Wave Life Sciences Ltd
Company Analysis
Latest News
🟢 Wave Life Sciences is trading 5% up in after-hours trading
Wave Life Sciences is trading 5.45% up now at $5.32 after falling 16.89% to $5.04 during the August 11 regular session. - Management presented at the Bank of...
Wave Life Sciences' Revenue Crater Exposes the Brutal Math of Pre-Revenue Biotech — Can the Pipeline Justify the Burn?
Shares of Wave Life Sciences plunged 12.5% to $5.31 on August 11, as Wall Street punished the clinical-stage biotech for a second-quarter revenue miss so...
🔴 Wave Life Sciences is trading 13% down today after analysts cut 2026 revenue forecast
Wave Life Sciences is trading 12.52% down at $5.31 after analysts cut its 2026 revenue forecast to $52 million from $59 million. - Second-quarter revenue was...
🔴 Wave Life Sciences is trading 5% down today after analysts cut 2026 revenue forecasts
Wave Life Sciences is trading 5.11% down at $5.76 after analysts reduced 2026 revenue expectations to $52 million from $59 million. - Disappointing...
Wave Life Sciences Completes Delaware Move as Analysts Slash Revenue Forecasts
Wave Life Sciences completed its corporate redomiciliation from Singapore to Delaware. The company’s common stock began trading on NASDAQ under the existing...
🟢 Wave Life Sciences is trading 5.3% up in pre-market ahead of Singapore-to-U.S. redomiciliation
Wave Life Sciences is trading at $6.34, up 5.34% in pre-market ahead of its planned Singapore-to-U.S. redomiciliation, expected after the August 7 close. -...
🔴 Wave Life Sciences is trading 5.1% down today after a wider Q2 loss and revenue miss
Wave Life Sciences is trading 5.1% down at $5.43 after reporting a wider-than-expected second-quarter loss and revenue that missed analyst estimates. • The...
🔴 Wave Life Sciences is trading 5.4% down today after a wider-than-expected Q2 loss and revenue miss
Wave Life Sciences is trading 5.4% down at $5.73 after reporting a wider-than-expected second-quarter loss and a sharp revenue decline compared to the previous...
Wave Life Sciences Posts Ugly Q2 Miss — Can Pipeline Promises Keep Investors From Heading for the Exits?
Shares shifted sharply lower as Wave Life Sciences reported second-quarter 2026 results that badly undershot Wall Street expectations, raising fresh questions...
🔴 Wave Life Sciences is trading 7.4% down today after reporting a wider-than-expected Q2 loss and revenue miss
Wave Life Sciences is trading 7.4% down at $5.38 after reporting a wider-than-expected second quarter loss and revenue that missed analyst estimates. • The...
Wave Life Sciences reports wider-than-expected second quarter loss as revenue misses estimates, while advancing key clinical programs.
Wave Life Sciences reported second quarter 2026 revenue of $2.3 million, down from $8.7 million in the prior-year period, alongside a net loss of $69.4...
Wave Life Sciences Ltd Q2 2026 Earnings Preview: What Analysts Expect on July 30, 2026
Consensus estimates project a Q2 2026 loss of $0.31 per share on revenue of $7.45 million, while the current stock price of $5.81 reflects a significant...
🔴 Wave Life Sciences is trading 5% down today as investors eye redomiciliation court hearing
Wave Life Sciences is trading at $5.93 (-5.04%) today as investors focus on the upcoming July 14 Singapore court hearing regarding its redomiciliation plan. •...
🔴 Wave Life Sciences is trading 5.3% down today as redomiciliation court hearing preparations continue
• Wave Life Sciences is trading at $5.97 (down 5.3%). • The company announced on July 7, 2026, a Singapore Court Hearing on July 14, 2026, to approve its...